5.3 Common Neonatal Complications

5.3 Common Neonatal Complications

Perinatal nurses must rapidly identify, differentiate, and manage complex neonatal disorders in the immediate post-birth transition period. Respiratory distress, hyperbilirubinemia, and Neonatal Abstinence Syndrome (NAS) represent three of the most frequent and clinically challenging neonatal complications encountered on obstetric and newborn units.

---

Differential Diagnosis of Neonatal Respiratory Distress

Respiratory distress occurs in 4% to 7% of neonates. Differentiation among Transient Tachypnea of the Newborn (TTN), Respiratory Distress Syndrome (RDS), and Meconium Aspiration Syndrome (MAS) is vital to guide targeted therapy.

Clinical Comparison Matrix

Critical NRP 9th Edition Update on Meconium-Stained Fluid

Historically, non-vigorous infants born through meconium-stained amniotic fluid (MSAF) underwent routine direct laryngoscopy and endotracheal suctioning prior to ventilation. Current NRP guidelines explicitly state that routine intubation and suctioning for non-vigorous meconium-stained infants is NO LONGER recommended. If an infant born through MSAF is non-vigorous (apneic, gasping, or HR < 100 bpm), the nurse must initiate Positive Pressure Ventilation (PPV) immediately within the Golden Minute.

---

Neonatal Hyperbilirubinemia & Phototherapy Protocols

Hyperbilirubinemia results from the accumulation of unconjugated (indirect) lipophilic bilirubin in the skin and sclera. Unconjugated bilirubin is a byproduct of hemoglobin breakdown from senescent red blood cells.

Evaluation & Treatment Framework

Jaundice within the first 24 hours requires prompt bilirubin measurement and evaluation. A bilirubin rise greater than about 0.3 mg/dL/hour in the first 24 hours or 0.2 mg/dL/hour thereafter suggests hemolysis and prompts evaluation.

Use AAP 2022 hour-specific phototherapy and exchange thresholds, selected by gestational age and neurotoxicity risk factors. Do not use the older Bhutani “risk-zone” nomogram as the treatment threshold. A positive direct antiglobulin test supports immune hemolysis, but ABO incompatibility can occur without a positive test. Elevated direct/conjugated bilirubin is never physiologic and requires evaluation.

Etiologies of Pathological Hyperbilirubinemia

• ABO Incompatibility: Mother is Type O (has anti-A and anti-B IgG antibodies that cross placenta); infant is Type A or B. DAT may be positive and supports immune hemolysis, but a negative DAT does not by itself exclude clinically important ABO-associated jaundice.
• Rh Isoimmunization: Rh-negative mother sensitized to Rh-positive fetus.
• RBC Structural/Enzyme Defects: G6PD deficiency, hereditary spherocytosis.
• Extravascular Hemorrhage: Cephalohematoma, extensive bruising, vacuum extraction hematoma.

Acute Bilirubin Encephalopathy & Kernicterus

Unbound, unconjugated bilirubin crosses the blood-brain barrier, depositing in the basal ganglia and brainstem nuclei:

• Acute Bilirubin Encephalopathy (Early Signs): Lethargy, hypotonia, poor feeding, high-pitched cry. Progresses to retrocollis-opisthotonos (arching of neck and back), hypertonia, fever, and seizures.
• Kernicterus (Chronic Permanent Injury): Choreoathetoid cerebral palsy, sensorineural hearing loss, enamel hypoplasia of primary teeth, and upgaze paresis.

Phototherapy Nursing Management

Intensive phototherapy uses light in the blue-green spectrum (wavelength 460 to 490 nm) to convert unconjugated bilirubin into lumirubin—a water-soluble structural photoisomer that is excreted in bile and urine without requiring hepatic conjugation.

• Eye Protection: Opaque eye patches must cover the eyes completely to prevent retinal damage. Check eye shield placement every 2 to 4 hours.
• Skin Exposure: Expose maximum skin surface area; dress infant only in a small diaper.
• Temperature Regulation: Monitor axillary temperature every 2 to 4 hours to prevent hyperthermia or hypothermia from phototherapy lights.
• Hydration & Stooling: Encourage frequent breast- or formula-feeding every 2 to 3 hours to enhance gastrointestinal motility and stool excretion (lumirubin is excreted in stool; stools become loose and bright green). Do NOT administer plain water or dextrose water.
• Lab Monitoring: Protect the collected bilirubin specimen from light and deliver it promptly according to laboratory procedure. Do not interrupt intensive phototherapy longer than necessary for feeding, care, or sampling.

---

Neonatal Abstinence Syndrome (NAS) / NOWS

Neonatal opioid withdrawal syndrome (NOWS) is the withdrawal syndrome after prenatal opioid exposure. Other medication or substance exposures can cause neonatal adaptation or withdrawal findings, but they should not all be labeled NOWS.

Clinical Presentation & Onset

Withdrawal symptoms typically manifest within 24 to 72 hours post-birth (up to 5 to 7 days for long-acting opioids like methadone or buprenorphine):

• Central Nervous System: High-pitched, continuous crying; sleep duration < 1 to 3 hours after feeding; hyperreflexia; exaggerated Moro reflex; tremors at rest; hypertonia; frantic fist sucking; seizures.
• Gastrointestinal: Uncoordinated suck/swallow; excessive unquenchable sucking; frequent regurgitation/projectile vomiting; loose watery stools; severe perianal diaper dermatitis.
• Autonomic Instability: Fever; diaphoresis; nasal stuffiness; sneezing (> 3-4 times in a row); yawning; tachypnea (> 60 bpm); skin mottling.

Assessment Models

Neonatal opioid withdrawal syndrome (NOWS) refers specifically to withdrawal after opioid exposure; neonatal abstinence syndrome is broader. A modified Finnegan tool scores signs, while Eat, Sleep, Console assesses function and caregiver involvement. Medication thresholds are protocol-specific; do not apply a universal “three scores of 8” rule.

Evidence-Based Nursing Interventions

• Non-Pharmacological (First-Line for ALL Infants):
  • Priority: Rooming-in with mother in a low-stimulation environment (dim lights, quiet room, minimal visitor noise).
  • Tight swaddling with flexed extremities; skin-to-skin contact.
  • Small, frequent, cue-based feedings with lactation and nutrition support; caloric density is individualized rather than automatically increased for every infant.
  • Non-nutritive sucking (pacifier).
• Pharmacological Therapy: Indicated when non-pharmacological care fails to maintain ESC criteria or FNASS thresholds are breached. First-line agents: Oral Morphine solution or Oral Methadone. Second-line adjuncts: Clonidine (for persistent adrenergic symptoms) or Phenobarbital (for non-opioid/polysubstance withdrawal).

---

Gestational-Age Assessment, Late-Preterm Risk & Transport

Estimate gestational age from the best obstetric dating and the newborn examination; a structured physical and neuromuscular assessment can support the estimate when dating is uncertain but is less precise than reliable prenatal dating. Assess posture, tone, reflexes, state regulation, feeding coordination, skin, plantar creases, ear and breast tissue, and genital maturity without letting one sign determine age.

Late-preterm infants may look mature yet have increased risk of hypothermia, hypoglycemia, respiratory distress, apnea, ineffective feeding, dehydration, jaundice, infection, and readmission. Before discharge, demonstrate stable temperature and cardiorespiratory transition, adequate feeding and output, bilirubin and glucose follow-up where indicated, a safe car-seat plan, caregiver teach-back, and an early follow-up appointment.

For a newborn who needs higher-level care, stabilize airway, breathing, circulation, temperature, and glucose; secure lines and tubes; communicate using a structured handoff; send records, maternal history, cord gases and specimens as applicable; and support family contact. Transport should not delay lifesaving stabilization, and the receiving neonatal team should be activated early.

---

Screening, Infection, Birth Injury & Congenital Findings

Before discharge, verify completion or documented follow-up for jurisdictional blood-spot screening, hearing screening, and critical congenital heart disease screening with preductal and postductal oxygen saturation. Screening does not diagnose disease; an abnormal result needs timely confirmation.

Early-onset sepsis may present with temperature instability, respiratory distress, poor perfusion, lethargy, feeding difficulty, glucose instability, apnea, or seizures. Risk assessment includes gestational age, maternal infection findings, membrane-rupture duration, GBS status and prophylaxis, and the infant's examination. Escalate an ill-appearing infant immediately; do not wait for fever.

Assess for clavicle injury, brachial plexus weakness, asymmetric movement, subgaleal hemorrhage, cephalohematoma, hip instability, imperforate anus, cleft lip/palate, genital findings, and other anomalies. Rapidly expanding scalp swelling crossing sutures with pallor or tachycardia suggests subgaleal hemorrhage and demands emergency evaluation. Stabilize first, protect feeding and airway, communicate with the family, and arrange specialty follow-up.